Joong‐Won Park
National Cancer Center(KR)Myongji Hospital(KR)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cancer Genomics and Diagnostics, Cancer Mechanisms and Therapy, Hepatitis B Virus Studies
Most-Cited Works
- → Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial(2018)5,305 cited
- → Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma(2018)2,297 cited
- → Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma(2014)1,526 cited
- → Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study(2015)1,232 cited
- → Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study(2013)766 cited
- → Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial(2013)763 cited